Výsledky vyhledávání - "Cardiovascular Diseases / drug therapy"

Akademický článek

Assessment of Drug Related Problems and Pharmacist Interventions in Inpatients with Cardiovascular Disease

Autor: S. M. Biradar, B. Kohima, V. Nayak, S. Nandikol, V. Warad, S. M. Byakod, B. S. Hunasagi, S. R. Awasthi

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 18, Iss 5, Pp 536-543 (2022)

Aim. To identify and evaluate the nature and incidence of drug-related problems (DRPs) and to manifest the role of a pharmacist in ensuring safe and efficient use of medications with cardiovascular disease patients by using PCNE Classification to ass

Externí odkaz: https://doaj.org/article/788cc685b45f43068ded2d2b722cd9cb

Zobrazit plný text záznamu

Effect of a 12-week high-intensity exercise intervention:a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis - study protocol for a randomised controlled trial

Autor: Simon Jønck, Malte Lund Adamsen, Pil Højgaard, Iben Elmerdahl Rasmussen, Helga Ellingsgaard, Morten Asp Vonsild Lund, Peter Godsk Jørgensen, Søren Jacobsen, Lars Køber, Niels Vejlstrup, Lene Dreyer, Bente Klarlund Pedersen, Ronan M G Berg, Regitse Højgaard Christensen

Publikováno v: Jønck, S, Adamsen, M L, Højgaard, P, Rasmussen, I E, Ellingsgaard, H, Lund, M A V, Jørgensen, P G, Jacobsen, S, Køber, L, Vejlstrup, N, Dreyer, L, Pedersen, B K, Berg, R M G & Christensen, R H 2023, ' Effect of a 12-week high-intensity exercise intervention : a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis-study protocol for a randomised controlled trial ', BMJ Open, vol. 13, no. 5, e068600 . https://doi.org/10.1136/bmjopen-2022-068600

Introduction The chronic inflammatory state in rheumatoid arthritis (RA) augments the risk of cardiovascular disease (CVD), with pro-inflammatory cytokines tumour necrosis factor (TNF) and interleukin 6 (IL-6) playing a vital role. Consequently, biol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91ea5918ca6c1f33c8b2dc9cecd88996
https://vbn.aau.dk/da/publications/396ea2ac-7ba4-4100-a9a4-f9006a48dff7

Zobrazit plný text záznamu

Temporal Trends in Low-Dose Aspirin Use (from the CoLaus|PsyCoLaus Study)

Autor: Elodie Drai, Pedro Marques-Vidal, Murielle Bochud, Julien Vaucher

Publikováno v: The American journal of cardiology, vol. 190, pp. 61-66

Although established in secondary prevention, the use of low-dose aspirin for primary cardiovascular prevention remains uncertain. We assessed the temporal trend of low-dose aspirin use in people at primary and secondary prevention over 14 years. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6787dfc5c7740642cea92c1fbea4c729
https://serval.unil.ch/notice/serval:BIB_B25215A4CE2A

Zobrazit plný text záznamu

Linee guida ESC 2021 per la prevenzione delle malattie cardiovascolari nella pratica clinica elaborate dalla Task Force per la prevenzione delle malattie cardiovascolari nella pratica clinica costituita da rappresentanti della Società Europea di Cardiologia e di 12 società medico-scientifiche con il contributo straordinario dell’Associazione Europea di Cardiologia Preventiva (EAPC)

Autor: ESC Scientific Document Group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::6b55e39cc0b5f085194018f8985e8774
https://doi.org/10.1714/3808.37926

Zobrazit plný text záznamu

Vitamin D Status, Cardiovascular Risk Profile, and miRNA-21 Levels in Hypertensive Patients: Results of the HYPODD Study

Autor: Domenico Rendina, Lanfranco D′Elia, Veronica Abate, Andrea Rebellato, Ilaria Buondonno, Mariangela Succoio, Fabio Martinelli, Riccardo Muscariello, Gianpaolo De Filippo, Patrizia D′Amelio, Francesco Fallo, Pasquale Strazzullo, Raffaella Faraonio

Publikováno v: Nutrients; Volume 14; Issue 13; Pages: 2683
Nutrients, vol. 14, no. 13, pp. 2683

The vitamin D and microRNA (miR) systems may play a role in the pathogenesis of cardiometabolic disorders, including hypertension. The HYPODD study was a double-blind placebo-controlled trial aiming to assess the effects of cholecalciferol treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c58707347f04853202e5bbee3453d69
https://pubmed.ncbi.nlm.nih.gov/35807864

Zobrazit plný text záznamu

Akademický článek

The prevalence of alternative herbal medicine and nutritional complementary product intake in patients admitted to out-patient cardiology departments

Autor: Esra Gücük İpek, Yeşim Güray, Burcu Demirkan, Ümit Güray, Habibe Kafes, Funda Başyiğit

Publikováno v: Türk Kardiyoloji Derneği Arşivi, Vol 41, Iss 3, Pp 218-224 (2013)

Objectives: To detect the prevalence of alternative herbal medicine and nutritional complementary product intake in patients admitted to outpatient cardiology clinics and to determine demographic characteristics, comorbidities and medical properties

Externí odkaz: https://doaj.org/article/97312323b5474bf6bc105bb0e432ae68

Zobrazit plný text záznamu

Endothelial dysfunction in COVID-19

Publikováno v: Cardiovascular Research. 116(14):2177-2184

The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also affects the cardiovascular system. In addition to cardiac effects, e.g. m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od________83::6fc922d88355e76fd1921f77921ddba5
https://doi.org/10.1093/cvr/cvaa230

Zobrazit plný text záznamu

Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial

Autor: Paris J Baptiste, Angel Y S Wong, Anna Schultze, Marianne Cunnington, Johannes F E Mann, Catherine Clase, Clémence Leyrat, Laurie A Tomlinson, Kevin Wing

Publikováno v: Baptiste, P J, Wong, A Y S, Schultze, A, Cunnington, M, Mann, J F E, Clase, C, Leyrat, C, Tomlinson, L A & Wing, K 2022, ' Effects of ACE inhibitors and angiotensin receptor blockers : Protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial ', BMJ Open, vol. 12, no. 3, e051907 . https://doi.org/10.1136/bmjopen-2021-051907

IntroductionCardiovascular disease is a leading cause of death globally, responsible for nearly 18 million deaths worldwide in 2017. Medications to reduce the risk of cardiovascular events are prescribed based on evidence from clinical trials which e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f9155d32afd30d32c79d7e7fe86ea6
https://pubmed.ncbi.nlm.nih.gov/35260450

Zobrazit plný text záznamu

Report from the CVOT Summit 2021:new cardiovascular, renal, and glycemic outcomes

Publikováno v: Schnell, O, Battelino, T, Bergenstal, R, Blüher, M, Böhm, M, Brosius, F, Carr, R D, Ceriello, A, Forst, T, Giorgino, F, Guerci, B, Heerspink, H J L, Itzhak, B, Ji, L, Kosiborod, M, Lalić, N, Lehrke, M, Marx, N, Nauck, M, Rodbard, H W, Rosano, G M C, Rossing, P, Rydén, L, Santilli, F, Schumm-Draeger, P-M, Vandvik, P O, Vilsbøll, T, Wanner, C, Wysham, C & Standl, E 2022, ' Report from the CVOT Summit 2021 : new cardiovascular, renal, and glycemic outcomes ', Cardiovascular Diabetology, vol. 21, no. 1, 50 . https://doi.org/10.1186/s12933-022-01481-0
Cardiovascular diabetology 21, 50 (2022). doi:10.1186/s12933-022-01481-0
Cardiovascular Diabetology, 21:50. BioMed Central Ltd.

Cardiovascular diabetology 21, 50 (2022). doi:10.1186/s12933-022-01481-0
Published by BioMed Central, London

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9d83661eb396006bdb2429ffbd233bc
https://curis.ku.dk/portal/da/publications/report-from-the-cvot-summit-2021(989b36e6-8c9d-4ef0-b4d5-83b0e07c4633).html

Zobrazit plný text záznamu

Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: a bedside-to-bench approach

Autor: Rasmus R. Mikkelsen, Malthe P. Hundahl, Christopher K. Torp, Javier Rodríguez-Carrio, Mads Kjolby, Jens M. Bruun, Tue W. Kragstrup

Publikováno v: Scopus
Mikkelsen, R R, Hundahl, M P, Torp, C K, Rodríguez-Carrio, J, Kjolby, M, Bruun, J M & Kragstrup, T W 2022, ' Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus : A bedside-to-bench approach ', European Journal of Pharmacology, vol. 925, 174998 . https://doi.org/10.1016/j.ejphar.2022.174998

OBJECTIVE: To assess which immunosuppressive drugs have been investigated and proven efficacious in patients with cardiovascular disease (CVD) or type 2 diabetes (T2D) without preexisting immune mediated disorders to validate in vitro and animal mode

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f756fa0c7d520da4cd8a98288ea820d
http://hdl.handle.net/10651/65535

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání